
Megakaryon Corporation Initiates First-in-Human Clinical Trial of Allogenic Human iPSC-Derived HLA Homozygous Platelets (MEG-002)
KYOTO, Japan–(BUSINESS WIRE)–Megakaryon Corporation (hereinafter, Megakaryon) today announces its clinical trial of allogenic human iPSC-derived HLA homozygous platelets (Development Code: MEG-002) in collaboration with Kyoto […]




